CORRECTING and REPLACING Terradepth’s Absolute Ocean Cleared Selection Process and Placed in NIWC Atlantic RCC Hopper
Placement in the RCC Hopper could enable direct prototype awards without further competition, accelerating Navy adoption for unmanned undersea operations AUSTIN,... Read more.
CORRECTING and REPLACING Terradepth’s Absolute Ocean Cleared Selection Process and Placed in NIWC Atlantic RCC Hopper
Placement in the RCC Hopper could enable direct prototype awards without further competition, accelerating Navy adoption for unmanned undersea operations AUSTIN,... Read more.
CORRECTING and REPLACING Terradepth’s Absolute Ocean Cleared Selection Process and Placed in NIWC Atlantic RCC Hopper
Placement in the RCC Hopper could enable direct prototype awards without further competition, accelerating Navy adoption for unmanned undersea operations AUSTIN,... Read more.
REMINDER: Atara Biotherapeutics, Inc. Investors With Significant Losses Must Act By May 22, 2026 – Contact Kirby McInerney LLP
NEW YORK–(BUSINESS WIRE)–Kirby McInerney LLP reminds Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ:ATRA) investors of the May... Read more.
Virtus Dividend, Interest & Premium Strategy Fund Announces Tender Offer
HARTFORD, Conn.–(BUSINESS WIRE)–Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the “Fund”) today announced that its Board of... Read more.
Davidson Bogel Real Estate Facilitates Multi-Parcel Assembly for Lovett Industrial Development Project in Lewisville, Texas
LEWISVILLE, Texas–(BUSINESS WIRE)–Davidson Bogel Real Estate (DB2RE) successfully facilitated the acquisition of an 8.5-acre, four-owner industrial... Read more.
REPAY Confirms Receipt of Unsolicited, Non-Binding Proposal from Forager Capital Management
No Stockholder Action is Required at this Time ATLANTA–(BUSINESS WIRE)–Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”),... Read more.
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer
First study combining botensilimab (BOT) and balstilimab (BAL) with agenT-797 in gastroesophageal cancer shows disease control rate (DCR) of 77% in patients and... Read more.
Republic Airways Announces Webcast of First Quarter 2026 Financial Results
CARMEL, Ind.–(BUSINESS WIRE)–Republic Airways Holdings Inc. (NASDAQ: RJET) will host a live conference call and webcast after the market closes to discuss... Read more.
Republic Airways Announces Webcast of First Quarter 2026 Financial Results
CARMEL, Ind.–(BUSINESS WIRE)–Republic Airways Holdings Inc. (NASDAQ: RJET) will host a live conference call and webcast after the market closes to discuss... Read more.